Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;79(8):1765-1776.
doi: 10.1161/HYPERTENSIONAHA.121.18881. Epub 2022 May 24.

Effects of Blood Pressure According to Age on End-Stage Renal Disease Development in Patients With Diabetes: A Nationwide Population-Based Cohort Study

Eun Hui Bae  1 , Sang Yeob Lim  2 , Bongseong Kim  3 , Tae Ryom Oh  1 , Su Hyun Song  1 , Sang Heon Suh  1 , Hong Sang Choi  1 , Eun Mi Yang  4 , Chang Seong Kim  1 , Seong Kwon Ma  1 , Kyung-Do Han #  3 , Soo Wan Kim #  1
Affiliations

Effects of Blood Pressure According to Age on End-Stage Renal Disease Development in Patients With Diabetes: A Nationwide Population-Based Cohort Study

Eun Hui Bae et al. Hypertension. 2022 Aug.

Abstract

Background: Recent hypertension guidelines have recommended lower blood pressure (BP) targets in high-risk patients. However, there are no specific guidelines based on age or systolic and diastolic blood pressure (SBP and DBP, respectively). We aimed to assess the effects of age-related BP on development of end-stage renal disease (ESRD) in patients with diabetes.

Methods: A total of 2 563 870 patients with diabetes aged >20 years were selected from the Korean National Health Screening Program from 2009 to 2012 and followed up until the end of 2019. Participants were categorized into age and BP groups, and the hazard ratios for ESRD were calculated.

Results: During a median follow-up of 7.15 years, the incidence rates of ESRD increased with increasing SBP and DBP. The hazard ratio for ESRD was the highest in patients younger than 40 years of age with DBP≥100 mm Hg. The effect of SBP and DBP on ESRD development was attenuated with age (interaction P was <0.0001 for age and SBP, and 0.0022 for age and DBP). The subgroup analysis for sex, antihypertension medication, and history of chronic kidney disease showed higher hazard ratios for ESRD among males, younger than 40 years, not taking antihypertension medications and chronic kidney disease compared to those among females, older than 40 years, antihypertension medication, and nonchronic kidney disease groups.

Conclusions: Higher SBP and DBP increase the risk of developing ESRD in patients with diabetes, and in particular, younger individuals face greater risk. Therefore, intensive BP management is warranted in younger patients to prevent ESRD.

Keywords: blood pressure; cardiovascular diseases; hypertension; kidney diseases; young adult.

PubMed Disclaimer

Figures

Figure.
Figure.
Incidence rate (IR) and hazard ratios (HR) for end-stage renal disease according to blood pressure group with age. Systolic blood pressure (A) and diastolic blood pressure (B). Adjusted for age, sex, income-low 25%, current smoker, alcohol consumption, regular exercise, hypertension, dyslipidemia, chronic kidney disease, diabetes duration ≥5 y, insulin, oral hypoglycemic agents ≥3.
See this image and copyright information in PMC

Comment in

References

    1. Kastarinen M, Juutilainen A, Kastarinen H, Salomaa V, Karhapää P, Tuomilehto J, Grönhagen-Riska C, Jousilahti P, Finne P. Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland. J Intern Med. 2010;267:612–620. doi: 10.1111/j.1365-2796.2009.02197.x - PubMed
    1. Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, et al. ; American Heart Association, American College of Cardiology, and American Society of Hypertension. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the american heart association, american college of cardiology, and american society of hypertension. Circulation. 2015;131:e435–e470. doi: 10.1161/CIR.0000000000000207 - PMC - PubMed
    1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC). Eur Heart J. 2013;34:2159–2219. doi: 10.1093/eurheartj/eht151 - PubMed
    1. Hinton TC, Adams ZH, Baker RP, Hope KA, Paton JFR, Hart EC, Nightingale AK. Investigation and treatment of high blood pressure in young people: too much medicine or appropriate risk reduction? Hypertension. 2020;75:16–22. doi: 10.1161/HYPERTENSIONAHA.119.13820 - PubMed
    1. Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Hypertension. 2018;71:e13–e115. doi: 10.1161/HYP.0000000000000065 - PubMed

Publication types

Substances